Welcome to our dedicated page for Zevia Pbc SEC filings (Ticker: ZVIA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zevia PBC filings document the public-company disclosures of a Delaware public benefit corporation focused on zero-sugar, clean-label beverages. Form 8-K reports furnish quarterly and annual earnings releases, Regulation FD investor presentations, board appointments and committee assignments, and material agreements tied to the company’s capital structure.
Proxy materials describe annual meeting matters such as director elections, auditor ratification, board structure, committee oversight and stockholder voting procedures. Other filings address the company’s Class A common stock, its wholly owned subsidiary Zevia LLC, and equity distribution arrangements used for at-the-market offering capacity.
CDP Investissements Inc. and Caisse de depot et placement du Quebec filed Amendment No. 3 to their Schedule 13D on Zevia PBC, reporting beneficial ownership of 13,550,428 shares of Class A Common Stock, representing 20.1% of the class.
They report shared voting and dispositive power over all 13,550,428 shares and no sole power. The ownership percentage is based on 67,389,166 Zevia Class A shares outstanding as of October 31, 2025, as disclosed in Zevia’s Form 10-Q for the quarter ended September 30, 2025.
The amendment updates identity and background information for controlling persons and restates their interest in Zevia’s securities. It also notes that transactions in the last 60 days are listed in Annex B and, other than those, no additional trades were made during that period.
CDP Investissements Inc., a wholly owned subsidiary of Caisse de dépôt et placement du Québec and a 10% owner of Zevia PBC, reported selling 3,500,000 shares of Zevia Class A common stock on January 27, 2026 at $2 per share.
After this transaction, CDP Investissements Inc. reported beneficial ownership of 13,550,428 Class A shares, held directly. CDPQ may be deemed to beneficially own these shares through its 100% ownership of CDP Investissements Inc.
CDP Investissements Inc., a wholly owned subsidiary of Caisse de dépôt et placement du Québec (CDPQ), sold 2,971,664 shares of Zevia PBC Class A Common Stock at $2.73 per share on September 30, 2025. After this transaction, CDP directly held 17,050,428 shares. The Form 4 is filed jointly by CDPQ and CDP, with CDPQ potentially deemed a beneficial owner through its subsidiary relationship.
Zevia PBC has a shareholder planning to sell Class A common stock under Rule 144. The notice covers 3,500,000 shares with an aggregate market value of $7,175,000, to be sold through BMO Capital Markets on the NYSE, with 67,389,166 shares outstanding.
The shares trace back to a December 21, 2020 cash purchase of Series E Preferred Units in Zevia LLC, which were later converted into Zevia PBC Class A common stock in connection with the company’s IPO.
Zevia PBC director Suzanne Saltzman Ginestro filed a Form 3 indicating she currently holds no Zevia securities. The filing lists her relationship to the company as a director and confirms that no non-derivative or derivative securities are beneficially owned. The event date for this initial ownership report is noted as 01/07/2026.
Zevia PBC reported changes to its board of directors. The board appointed Suzanne Ginestro as an independent Class II director effective January 7, 2026, with her term running until the company’s 2026 annual meeting of stockholders, when she will be eligible for re-election. She will also serve on the board’s Compensation Committee and receive the standard compensation provided to non-employee directors, as described in the company’s 2025 annual meeting proxy statement.
The company also disclosed that director Justin Shaw notified Zevia on January 7, 2026 that he will step down from the board effective February 24, 2026. His resignation is not due to any disagreement with the company or the board over operations, policies, or practices. Zevia expects Ms. Ginestro to enter into its standard director and officer indemnification agreement and stated there are no related-party transactions requiring disclosure.
Zevia PBC (ZVIA) — Form 4 insider transaction: A director reported selling 200,000 shares of Class A Common Stock on 11/10/2025 at a weighted average price of $2.6439, with sales executed between $2.605 and $2.70. Following the sale, the director beneficially owns 1,595,417 shares, including 71,827 RSUs. The filing notes RSUs of 148,417 vest in 1/4 increments on each anniversary of March 17, 2022, and 34,722 RSUs vest on the earlier of June 12, 2026 or the 2026 annual meeting, with settlement within 30 days of vesting.
Zevia PBC (ZVIA) reported a Form 144 notice indicating a proposed sale of 200,000 shares of Class A common stock. The filing lists Merrill Lynch as broker, an approximate sale date of 11/10/2025, and trading on the NYSE, with an aggregate market value of $528,782.54.
The shares were acquired through vesting of restricted stock unit awards granted under the issuer’s equity compensation plan across multiple dates, matching the 200,000 shares to be sold. The filing notes 67,389,166 shares outstanding.
Zevia PBC reported Q3 2025 results showing higher sales and a narrower loss. Net sales were $40.844 million versus $36.366 million a year ago, with gross profit of $18.617 million. Loss from operations was $2.873 million, and net loss attributable to Zevia PBC was $2.686 million, or $0.04 per share.
For the first nine months, net sales reached $123.391 million (up from $115.591 million), and net loss attributable was $8.609 million versus $14.242 million last year, reflecting improved operating performance after restructuring actions.
Liquidity remained solid with $26.029 million in cash at quarter end and no borrowings outstanding on the $20 million revolving credit facility. The company established an at-the-market equity program of up to $20 million in August 2025 and did not issue shares during the quarter. As of October 31, 2025, there were 67,389,166 Class A shares and 7,614,823 Class B shares outstanding.
Zevia PBC furnished an 8‑K announcing its earnings release for the third quarter ended September 30, 2025. The company made the release available as Exhibit 99.1, dated November 5, 2025.
The information under Item 2.02, including Exhibit 99.1, is furnished and not deemed “filed” under Section 18 of the Exchange Act, and is not incorporated by reference unless expressly stated in a future filing. The report was signed by Girish Satya, Chief Financial Officer and Principal Accounting Officer.